I am delighted you have taken time to visit our website. I have the privilege and honour of leading a group of more than 100 multidisciplinary scientists and clinicians with world class expertise in chemistry related fields, large molecule research, small molecule biology platforms, diagnostic development, biomarker qualification, and exploratory clinical development.
EDDC fosters multidisciplinary efforts to commercialise biomedical R&D by working with all key players in the Singaporean Drug Discovery and Development Ecosystem. These include A*STAR Research Institutes, Universities, Hospitals, Phase 1 units, Regulatory Authority (HSA), Multinational Pharma, Biotech’s, Research Foundations & CRO's.
EDDC also provides feedback, education, and training for discovery and translational researchers to improve and build their knowledge and experience in Drug Discovery & Development.
Our core values are operating to the highest standards of scientific and clinical rigor and quality; behaving with integrity and impartiality; promoting research, innovation, having openness to change and a disposition to continual learning; treating stakeholders and each other with dignity and respect at all times.
Ultimately we are about leveraging great science to make great medicines for patients.
Damian O'Connell, MD BSc PhD
CEO Experimental Drug Development Centre
A*STAR - Agency for Science, Technology and Research, Singapore